ACHIEVE LIFE SCIENCES, INC. (ACHV) Executive Compensation
ACHIEVE LIFE SCIENCES, INC. (ACHV) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACHV
CIK: 949858
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerKate Furber
Audit LocationVancouver, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-05 | 4 Filing | 0001953943-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-10-06 | 2026-10-05 | 3 Filing | 0001953943-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-10-01 | 8-K | 0001193125-26-410781 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001193125-26-361182 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001949846-26-000528 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-17 | — | SCHEDULE 13G Filing | 0000935836-26-000426 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001193125-26-352229 | View SEC Doc Filr Page |
| 424B5 | 2026-08-14 | — | 424B5 | 0001193125-26-352154 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001274173-26-000193 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344624 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344571 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-324262 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-324256 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-324253 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-324250 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-324245 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-324238 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-324231 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0000038777-26-000201 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002256 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-08 | — | SCHEDULE 13G Filing | 0001213900-26-076390 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-07-02 | 8-K | 0001193125-26-296174 | View SEC Doc Filr Page |
| ARS | 2026-06-08 | 2025-12-31 | ARS | 0000949858-26-000007 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-08 | 2026-06-08 | DEF 14A | 0000949858-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-05-29 | 4 | 0002107415-26-000004 | View SEC Doc Filr Page |